Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 1Neoplasms 1Erectile Dysfunction 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Ambulatory Care Facilities × Clear all
NCT07048314 2026-03-19

Stem Cells for Erectile Dysfunction Post RALP

The Methodist Hospital Research Institute

Phase 1/2 Not yet recruiting
40 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

NCT00737646 2012-12-17

Evaluation of an Intervention to Increase Colorectal Cancer Screening in Primary Care Clinics

Centers for Disease Control and Prevention

Phase NA Completed
5,066 enrolled
Gastrointestinal

Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡